Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by A.J. Arribas
Development of Novel Preclinical Models of Secondary Resistance to the Pi3kδ Inhibitor Idelalisib in Splenic Marginal Zone Lymphoma (Smzl)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Related publications
Mechanisms of Secondary Resistance to Idelalisib in Marginal Zone Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Idelalisib and Rituximab in 17p Deletion–Positive Splenic Marginal Zone Lymphoma
Journal of the National Comprehensive Cancer Network : JNCCN
Medicine
Oncology
Multi-Omics Landscape of Splenic Marginal Zone Lymphoma (Smzl) - Interim Analysis of Ielsg46 Study
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Splenic Marginal Zone Lymphoma
A Case of Splenic Marginal Zone Lymphoma
Japanese Journal of Gastroenterological Surgery
Surgery
Gastroenterology
Rituximab Alone (R) Versus Rituximab Plus Bendamustine (Br) for Splenic (Smzl) and Nodal Marginal Zone Lymphoma (Nmzl)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Recurrent Autoimmune Hemolytic Anemia in Splenic Marginal Zone Lymphoma
Journal of Community Hospital Internal Medicine Perspectives
Internal Medicine
Primary Splenic Marginal Zone Lymphoma: A Case Report
Pathology
Forensic Medicine
Pathology
CD79B and MYD88 Mutations in Splenic Marginal Zone Lymphoma
ISRN Oncology